TRANSCODE THERAPEUTICS
Live / Applied — Statement of use — non-final action mailed (as of 25 Jun 2026)
What this means for you
Not registered yet, but its 20 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97083236
- Mark type
- Word mark
- Filed
- 20 Oct 2021
- Published for opposition
- 04 Apr 2023
- Attorney of record
- Jing Liu
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; diagnostic preparations for medical purposes
Owner
- TransCode Therapeutics, Inc., Boston, MA, US
- TransCode Therapeutics, Inc., Boston, MA, US
Prosecution history
- 23 Sept 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 23 Sept 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 30 Jun 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jun 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Jun 2026 — NON-FINAL ACTION E-MAILED
- 25 Jun 2026 — SU - NON-FINAL ACTION - WRITTEN
- 08 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 May 2026 — USE AMENDMENT FILED
- 26 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 30 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2026 — SOU EXTENSION 5 GRANTED
- 13 Nov 2025 — SOU EXTENSION 5 FILED